Related Experiment Video

Updated: May 28, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

Cardiovascular effects of dexmedetomidine sedation in children

Jackson Wong1, Garry M Steil, Michelle Curtis

  • 1Department of Medicine, Medicine Critical Care Program, Children's Hospital Boston and Harvard Medical School, MA, USA. Jackson.Wong@childrens.harvard.ed

Anesthesia and Analgesia
|October 4, 2011
PubMed

Insights

Dexmedetomidine (DEX) sedation in children significantly decreases cardiac index (CI). Prolonged DEX use leads to sustained reductions in heart rate (HR), CI, and stroke index (SI), with increased systemic vascular resistance index (SVRI).

Area of Science:

  • Pediatric Anesthesiology
  • Cardiovascular Pharmacology
  • Sedation Management

Background:

  • Dexmedetomidine (DEX) is known to affect cardiovascular parameters in adults.
  • The impact of DEX on pediatric hemodynamics during sedation requires further investigation.

Purpose of the Study:

  • To determine the effects of DEX sedation on hemodynamic variables in children.
  • To compare cardiovascular changes in children receiving brief versus prolonged DEX sedation.

Main Methods:

  • Prospective study of pediatric patients undergoing IV DEX sedation for radiological procedures.
  • Two groups: DEX-brief (≤10 min) and DEX-prolong (>10 min).
  • Continuous noninvasive cardiac output monitoring to assess cardiac index (CI), stroke index (SI), and systemic vascular resistance index (SVRI).

Main Results:

  • Dexmedetomidine (DEX) administration led to decreased heart rate (HR) and cardiac index (CI) in the DEX-brief group.
  • In the DEX-prolong group, HR and CI remained decreased at discharge.
  • Prolonged DEX sedation also resulted in decreased SI and increased SVRI at discharge.

Conclusions:

  • Dexmedetomidine (DEX) significantly decreases cardiac index (CI) in pediatric patients.
  • The cardiovascular effects of DEX are cumulative, with prolonged administration impacting hemodynamics at discharge.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...